John Fung to Mice
This is a "connection" page, showing publications John Fung has written about Mice.
Connection Strength
0.701
-
Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells. Transpl Immunol. 2004 Jun-Jul; 13(1):15-24.
Score: 0.022
-
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. J Pharm Pharmacol. 2021 Aug 12; 73(9):1180-1190.
Score: 0.018
-
Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response. Stem Cell Res. 2018 05; 29:32-41.
Score: 0.014
-
C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants. Transplantation. 2017 08; 101(8):1793-1800.
Score: 0.014
-
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
Score: 0.013
-
Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1168-9.
Score: 0.013
-
CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal. J Biol Chem. 2017 Jan 13; 292(2):661-671.
Score: 0.013
-
Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration. Mol Ther. 2016 09; 24(9):1665-74.
Score: 0.013
-
Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage. Biomaterials. 2016 09; 102:209-19.
Score: 0.013
-
Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
Score: 0.013
-
Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis. J Leukoc Biol. 2016 Mar; 99(3):447-54.
Score: 0.012
-
Hepatic Stellate Cells Inhibit T Cells through Active TGF-ß1 from a Cell Surface-Bound Latent TGF-ß1/GARP Complex. J Immunol. 2015 Sep 15; 195(6):2648-56.
Score: 0.012
-
Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice. Hepatology. 2015 Sep; 62(3):915-31.
Score: 0.012
-
Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology. 1995 May; 85(1):82-7.
Score: 0.012
-
Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc. 1995 Feb; 27(1):509-10.
Score: 0.012
-
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc. 1995 Feb; 27(1):511-2.
Score: 0.012
-
Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis. J Immunol. 2014 Sep 01; 193(5):2127-34.
Score: 0.011
-
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Transplant Proc. 1994 Jun; 26(3):1211.
Score: 0.011
-
All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function. J Immunol. 2014 Jun 01; 192(11):5098-108.
Score: 0.011
-
Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase. Transplantation. 2014 Apr 15; 97(7):740-7.
Score: 0.011
-
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
Score: 0.010
-
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood. 2013 Mar 07; 121(10):1760-8.
Score: 0.010
-
Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):959-66.
Score: 0.009
-
Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation. 2012 Feb 15; 93(3):272-82.
Score: 0.009
-
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011 Mar; 53(3):1007-19.
Score: 0.009
-
The role of liver stromal cells in dendritic cells development in mice. Transplant Proc. 2010 Dec; 42(10):4279-81.
Score: 0.009
-
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011 Apr; 216(4):528-34.
Score: 0.008
-
A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery. 2010 May; 30(4):332-7.
Score: 0.008
-
Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology. 2009 Dec; 50(6):1981-91.
Score: 0.008
-
Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol. 2009 Sep; 51(3):510-9.
Score: 0.008
-
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation. 2008 Dec 15; 86(11):1492-502.
Score: 0.008
-
The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology. 2007 Feb; 120(2):251-60.
Score: 0.007
-
Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells. Transplant Proc. 2007 Jan-Feb; 39(1):281-2.
Score: 0.007
-
ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation. Microsurgery. 2007; 27(4):328-32.
Score: 0.007
-
Cotransplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery. 2007; 27(4):324-7.
Score: 0.007
-
In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulation. Liver Transpl. 2006 Dec; 12(12):1850-61.
Score: 0.007
-
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 2006 Nov; 44(5):1171-81.
Score: 0.006
-
Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. J Heart Lung Transplant. 2006 Mar; 25(3):310-9.
Score: 0.006
-
Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death. Microsurgery. 2006; 26(1):21-4.
Score: 0.006
-
Immune regulatory activity of liver-derived dendritic cells generated in vivo. Microsurgery. 2006; 26(1):17-20.
Score: 0.006
-
Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol. 2005 Jul; 131(7):429-38.
Score: 0.006
-
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg. 2005 Mar; 241(3):497-505.
Score: 0.006
-
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
Score: 0.006
-
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. Transplant Proc. 2004 Jun; 36(5):1592-4.
Score: 0.005
-
Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol. 2004 Feb 01; 172(3):1355-63.
Score: 0.005
-
Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58. Transpl Int. 2003 Dec; 16(12):849-56.
Score: 0.005
-
Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
Score: 0.005
-
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes. 2003 Aug; 52(8):1976-85.
Score: 0.005
-
Prolonged survival of heart allografts transduced with AAV-CTLA4Ig. Microsurgery. 2003; 23(5):489-93.
Score: 0.005
-
Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
Score: 0.005
-
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
Score: 0.005
-
Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function. Transplant Proc. 2002 Aug; 34(5):1394-5.
Score: 0.005
-
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
Score: 0.005
-
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
Score: 0.004
-
Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
Score: 0.004
-
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
Score: 0.004
-
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):129-30.
Score: 0.004
-
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
Score: 0.004
-
Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of posttransplant vasculopathy: salutary effects of perioperative costimulatory blockade. Transplant Proc. 2001 Feb-Mar; 33(1-2):307.
Score: 0.004
-
Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):319.
Score: 0.004
-
Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation. Transplant Proc. 2001 Feb-Mar; 33(1-2):382.
Score: 0.004
-
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. Transplant Proc. 2001 Feb-Mar; 33(1-2):525.
Score: 0.004
-
Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):604.
Score: 0.004
-
Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species. Transplant Proc. 2001 Feb-Mar; 33(1-2):710-1.
Score: 0.004
-
Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
Score: 0.004
-
Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology. 2000 Oct; 101(2):233-41.
Score: 0.004
-
Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice. Hepatology. 2000 Aug; 32(2):256-67.
Score: 0.004
-
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol. 2000 May; 156(5):1627-39.
Score: 0.004
-
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther. 2000 May; 1(5 Pt 1):430-7.
Score: 0.004
-
Maturation of B-cell clones. Prog Clin Biol Res. 1980; 42:203-14.
Score: 0.004
-
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
Score: 0.004
-
Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
Score: 0.004
-
Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation. 1999 May 27; 67(10):1295-300.
Score: 0.004
-
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Transplantation. 1999 Feb 15; 67(3):444-50.
Score: 0.004
-
Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses. Transplant Proc. 1999 Feb-Mar; 31(1-2):115.
Score: 0.004
-
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
Score: 0.004
-
Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant Proc. 1999 Feb-Mar; 31(1-2):784.
Score: 0.004
-
Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
Score: 0.004
-
Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface. Transplant Proc. 1999 Feb-Mar; 31(1-2):845.
Score: 0.004
-
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc. 1999 Feb-Mar; 31(1-2):1195.
Score: 0.004
-
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
Score: 0.004
-
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
Score: 0.004
-
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
Score: 0.004
-
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
Score: 0.004
-
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc. 1998 Jun; 30(4):941-2.
Score: 0.004
-
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
Score: 0.004
-
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
Score: 0.004
-
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
Score: 0.003
-
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997 May 15; 158(10):4654-61.
Score: 0.003
-
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1081-2.
Score: 0.003
-
Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1310.
Score: 0.003
-
Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996 Dec 27; 62(12):1709-14.
Score: 0.003
-
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996 Sep 15; 62(5):659-65.
Score: 0.003
-
Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. Transplantation. 1996 Apr 27; 61(8):1228-33.
Score: 0.003
-
Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts. Transplant Proc. 1996 Apr; 28(2):732.
Score: 0.003
-
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):733-4.
Score: 0.003
-
Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
Score: 0.003
-
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
Score: 0.003
-
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
Score: 0.003
-
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc. 1995 Feb; 27(1):191-3.
Score: 0.003
-
The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. Transplant Proc. 1995 Feb; 27(1):270.
Score: 0.003
-
Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
Score: 0.003
-
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
Score: 0.003
-
Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
Score: 0.003
-
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994 Apr; 19(4):916-24.
Score: 0.003
-
Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation. 1993 Oct; 56(4):905-11.
Score: 0.003
-
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation. 1993 Mar; 55(3):659-61.
Score: 0.003
-
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):414-5.
Score: 0.003
-
Xenoreactivity in mouse + rat-->mouse chimeras. Transplant Proc. 1993 Feb; 25(1 Pt 1):455-6.
Score: 0.003
-
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc. 1993 Feb; 25(1 Pt 1):704-5.
Score: 0.003
-
Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. Transplant Proc. 1992 Aug; 24(4):1605-6.
Score: 0.002
-
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. Transplant Proc. 1992 Jun; 24(3):1042.
Score: 0.002
-
Survival of human hepatocellular aggregates in athymic mice. Transplant Proc. 1992 Jun; 24(3):986.
Score: 0.002
-
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Transplant Proc. 1991 Dec; 23(6):2957-8.
Score: 0.002
-
Orthotopic liver transplantation in the mouse. Transplantation. 1991 Sep; 52(3):562-4.
Score: 0.002
-
Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. Transplant Proc. 1991 Feb; 23(1 Pt 1):705-6.
Score: 0.002